Publications in collaboration with researchers from Queen Elizabeth Hospital (1)

2018

  1. Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer

    New England Journal of Medicine, Vol. 379, Núm. 21, pp. 2027-2039